title: Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation.
authors: Renal Transplant Service, Hospital das Clínicas, Instituto Central, University of São Paulo School of Medicine, sala 7036, Av. Dr. Enéas de Carvalho Aguiar 255, São Paulo, SP, 05403-000, Brazil, igordenizarde@yahoo.com.br.
authors: Igor Denizarde Bacelar
authors: ID
authors: Marques
authors: Janaina
authors: J
authors: Ramalho
authors: Daísa Ribeiro
authors: DR
authors: David
authors: William Carlos
authors: WC
authors: Nahas
authors: Elias
authors: E
authors: David-Neto
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000276:immunology; D015415:Biomarkers / Q000652:urine; D001706:Biopsy; D005260:Female; D015432:Glomerulonephritis, Membranoproliferative / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008875:Middle Aged; D010956:Plasmapheresis; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D015415:Biomarkers; D007155:Immunologic Factors; D000069283:Rituximab